AGENDA
Thursday, July 25, 2019 | The Ritz-Carlton Chicago
Presented By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Senior Managing Director - Blackstone Life Sciences | DOWNLOAD PRESENTATION
Introduced By:
Jason Menzo, COO - Foundation Fighting Blindness
9:02 - 9:06 AM | Sparing Vision | José Sahel, MD, Chair, Department of Ophthalmology and The Eye & Ear Foundation Endowed Chair - University of Pittsburgh School of Medicine | DOWNLOAD PRESENTATION
9:06 - 9:12 AM | Eloxx Pharmaceuticals | Susan Schneider, MD, SVP, Clinical Development Ophthalmology
9:12 - 9:16 AM | Wave Life Sciences | Michael Byrne, PhD, Director in Vivo Biology, Ophthalmology | DOWNLOAD PRESENTATION
Introduced By:
Patrick Healy, MPH, Co-Founder, Executive Chairman - Trial Runners
9:16 - 9:22 AM | Opthea | Megan Baldwin, PhD, CEO & Managing Director | DOWNLOAD PRESENTATION
9:22 - 9:28 AM | AsclepiX Therapeutics | Wendy Perrow, CEO | DOWNLOAD PRESENTATION
9:28 - 9:34 AM | Belite Bio | Irene Wang, COO
9:34 - 9:40 AM | Allegro Ophthalmics | Vicken Karageozian, MD, President & CEO | DOWNLOAD PRESENTATION
9:40 - 9:46 AM | Stealth Biotherapeutics | Reenie McCarthy, CEO | DOWNLOAD PRESENTATION
9:46 - 9:52 AM | Alkahest | Elizabeth Jeffords, Chief Strategy Officer | DOWNLOAD PRESENTATION
9:52 - 9:58 AM | Eyedaptic | Jay Cormier, CEO | DOWNLOAD PRESENTATION
9:58 - 10:04 AM | Ocutrx | Michael Freeman, CEO | DOWNLOAD PRESETNATION
10:04 - 10:10 AM | Eyevensys | Patricia Zilliox, President & CEO | DOWNLOAD PRESENTATION
10:10 - 10:16 AM | Regenera | Jordan Rubinson, CEO | DOWNLOAD PRESENTATION
10:16 - 10:22 AM | Kodiak Sciences | Jason Ehrlich, MD, PhD, Chief Medical Officer & Chief Development Officer | DOWNLOAD PRESENTATION
Presented By:
Mihir Mantri, Managing Director - Piper Jaffray | DOWNLOAD PRESENTATION
Introduced By:
Susan Benton, Head, New Ophthalmic Products - Shire (A Takeda Company)
11:00 - 11:08 AM | EyePoint Pharmaceuticals | Scott Jones, Chief Commercial Officer | DOWNLOAD PRESENTATION
11:08 - 11:16 AM | Aerie Pharmaceuticals | Casey Kopczynski, PhD, Co-Founder & Chief Scientific Officer | DOWNLOAD PRESENTATION
11:16 - 11:24 AM | Adverum Biotechnologies | Mehdi Gasmi, PhD, President & Chief Scientific Officer | DOWNLOAD PRESENTATION
11:24 - 11:32 AM | Oxurion | Patrik De Haes, CEO | DOWNLOAD PRESENTATION
11:32 - 11:40 AM | REGENXBIO | Ram Palanki, PharmD, SVP, Commercial Strategy and Operations | DOWNLOAD PRESENTATION
Participants:
Emmett T. Cunningham Jr., MD, PhD, MPH, Senior Managing Director - Blackstone Life Sciences
Michael Keyoung, MD, PhD, Managing Director & Head, North America - C-Bridge Capital
Ash Khanna, PhD, Venture Partner - Pivotal bioVenture Partners
Firas M. Rahhal, MD, Partner - ExSight Ventures / Partner & Executive - Retina Vitreous Associates Medical Group
Ron Weiss, MD, Managing Partner - InFocus Capital Partners / Founder & Owner - Chicago Eye Consultants
Moderated By:
Pravin Dugel, MD - Retinal Consultants of Arizona
Genetic and Regenerative Therapy Overview
Presented By:
Glenn Yiu, MD, PhD, Associate Professor - University of California, Davis | DOWNLOAD PRESENTATION
Panel Discussion
Participants:
Thomas Ciulla, MD, MBA, Chief Medical Officer - Clearside Biomedical
Mehdi Gasmi, PhD,President & Chief Scientific Officer - Adverum Biotechnologies
Mark Humayun, MD, PhD, Professor of Ophthalmology - University of Southern California
Steve Pakola, MD, SVP & Chief Medical Officer - REGENXBIO
Glenn Yiu, MD, PhD, Associate Professor - University of California, Davis
Moderated By:
John Pollack, MD, Partner - Illinois Retina Associates
Company Presentations
2:15 - 2:20 PM | Graybug Vision | Fred Guerard, CEO | DOWNLOAD PRESENTATION
2:20 - 2:25 PM | Interface Biologics | Wendy Naimark, PhD, VP, R&D | DOWNLOAD PRESENTATION
2:25 - 2:30 PM | Re-Vana Therapeutics | Michael O'Rourke, President & CEO | DOWNLOAD PRESENTATION
Panel Discussion
Participants:
David Boyer, MD - Retina-Vitreous Associates Medical Group
Jay Duker, MD, Director - New England Eye Center / Co-Founder - Hemera Biosciences
Baruch Kuppermann, MD, PhD, Professor and Chair, Department of Ophthalmology, Gavin Herbert Eye Institute - University of California, Irvine
Moderated By:
Robert Avery, MD, Founder - California Retina Consultants
Company Presentations
3:25 - 3:30 PM | Pr3vent | Darius Moshfeghi, MD, Co-Founder | DOWNLOAD PRESENTATION
3:30 - 3:35 PM | Tracery Ophthalmics | Shelley Boyd, MD, President & CEO | DOWNLOAD PRESENTATION
3:35 - 3:40 PM | Genentech | Daniela Ferrara, MD, MSc, PhD, Medical Director, Ophthalmology | DOWNLOAD PRESENTATION
3:40 - 3:45 PM | Carl Zeiss Meditec | Niranchana Manivannan, PhD, Senior Staff Scientist, Clinical Research & Analytics Development | DOWNLOAD PRESENTATION
Panel Discussion
Participants:
Netan Choudhry, MD, Co-Founder & Medical Director - Vitreous Retina Macula Specialists of Toronto
Szilárd Kiss, MD, Director, Clinical Research & Chief, Retina Service - Weill Cornell Medicine
Darius Moshfeghi, MD, Professor of Ophthalmology, Director of Retina - Stanford University School of Medicine / Co-Founder - Pr3vent
Moderated By:
Timothy G. Murray, MD, Founding Director & CEO - Miami Ocular Oncology & Retina (MOOR)
Participant:
Christopher Brittain, MRCOphth, MD, MBA, Global Head, Ophthalmology, Clinical Development - Genentech
Ravi Durvasula, PhD, Retinal Surgical Instrumentation R&D - Alcon
Chuck Hess, VP & General Manager, US Surgical - Bausch + Lomb
Angelo Rago, Global Head, Ophthalmic Diagnostics - Carl Zeiss Meditec
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Senior Managing Director - Blackstone Life Sciences